ライフサイエンスコーパス: IIP

1 IIP has significant advantages in reducing glycemic vari

2 IIP in thick biotype and with immediate provisionalizati

3 IIP patients had shorter leukocyte telomeres than age-ma

4 IIP provides a more accurate measure of antiviral activi

5 IIP reduced blood glucose fluctuations compared with MDI

6 mild clinical hypoglycemia by 68% (P<.001); IIP also eliminated the weight gain associated with MDI

7 In a subset (10%), IIP patients had telomere lengths below the first percen

8 etic ion-imprinted polymer (Fe(3)O(4)@SiO(2)@IIP) was synthesized using 2-(2-aminophenyl)-1H-benzimid

9 update is a supplement to the previous 2002 IIP classification document.

10 146 EIP observations from 8 studies and 204 IIP observations from 35 studies.

11 A new magnetic Cu(II) IIP (Fe(3)O(4)@IIP-IDC) is synthesized by polymerization of Imidazole-4

12 ans of 7.54%+/-0.83% (MDI) vs 7.34%+/-0.79% (IIP).

13 ications have provided new information about IIPs.

14 Surgical and restorative factors affect IIP success rates.

15 Although IIP showed favorable outcomes for CBL changes, these res

16 or replace it with an implant with either an IIP or delayed protocol.

17 to determine the frequency of sites where an IIP protocol presented a high risk for inferior alveolar

18 study of patients with CTD-ILD (n = 46) and IIP controls (n = 51), seen at the University of Michiga

19 ic and intrinsic incubation periods (EIP and IIP), in the mosquito and human, respectively.

20 nd 0.435 [0.215-0.8] for IIP-PH, IPF-PH, and IIP-PH with nintedanib/pirfenidone background therapy),

21 sus IIP using bone graft with membrane" and "IIP using GBR versus conventional implant placement" whi

22 yses showed minimal difference in CBL around IIP with bone graft versus without bone graft and with I

23 This study looked into CBL changes around IIP primarily and further extracted the data to conduct

24 Meta-analyses showed less CBL loss around IIP compared with implant placement in healed bone.

25 demonstrated better CBL preservation around IIP compared with implant placement in healed/native bon

26 Similarly, platform switching around IIP showed better results compared with non-platform swi

27 ces among HRCT diagnostic categories between IIP and CTD-ILD.

28 rties of human lung fibroblasts from certain IIP patient groups can be modulated in a manner that is

29 ation and, hence, the progression of certain IIPs.

30 placement or use of immediate versus delayed IIP loading.

31 l categories as transcripts that distinguish IIP from normal samples.

32 patients with sporadic IIP, 10 with familial IIP, and 9 normal control subjects on a whole human geno

33 atistically significant differences favoring IIP, the small differences may not be clinically relevan

34 , bosentan, in patients with PH and fibrotic IIP.

35 -controlled study, 60 patients with fibrotic IIP and right heart catheter confirmed PH were randomize

36 nd DNA repair contribute to risk of fibrotic IIPs.

37 461 [0.233-0.913], and 0.435 [0.215-0.8] for IIP-PH, IPF-PH, and IIP-PH with nintedanib/pirfenidone b

38 he cut-off of 5, with a similar accuracy for IIP 0.687 and CTD-ILD 0.720 but not for HP.

39 nt predictors of mortality when adjusted for IIP versus CTD-ILD diagnosis, sex, and interstitial scor

40 econd molars had <6 mm of bone available for IIP, presenting high risk for inferior alveolar nerve in

41 eolar canal did not limit available bone for IIP, 7% of the second premolars, 9% of the first molars,

42 Comparable sizes are measured for IIP and IIP_Au NPs.

43 rve injury and lingual plate perforation for IIP in the posterior mandible.

44 econd molar teeth that present high risk for IIP using a preextraction CT scan to assess the availabl

45 mol/L (149.6+/-27.4 mg/dL) (mean +/- SD) for IIP and MDI, respectively (P=.57).

46 wn out of surgical lung biopsies (SLBs) from IIP patients based on their expression of interleukin-4

47 of "IIP using GBR versus IIP without GBR", "IIP using bone graft alone versus IIP using bone graft w

48 However, IIP with bone graft and membrane reported better CBL pre

49 However, IIP with bone graft and membrane showed better results w

50 However, IIP with bone graft and membrane showed better results w

51 A new magnetic Cu(II) IIP (Fe(3)O(4)@IIP-IDC) is synthesized by polymerization

52 Zn (II) IIP was prepared by copolymerisation of methyl methacryl

53 50), does not correlate well with changes in IIP when mutations alter slope.

54 chemokine receptor 7 (CCR7) is expressed in IIP biopsies and primary fibroblast lines, but its role

55 ficantly better PH maintenance were found in IIP with immediate provisionalization versus conventiona

56 MFR was slightly less in IIP with thick versus thin biotypes, but not statistical

57 cantly less MFR and better PH maintenance in IIP with thick biotype (MFR: MD -0.478, P <0.001; cumula

58 CBL preservation was noted in IIP with GBR versus conventional implant placement [CBL

59 CBL preservation was noted in IIP with GBR versus conventional implant placement [CBL

60 conventional implant placement (CIP) than in IIP, but the result was not statistically significant (m

61 Substantial progress has been made in IIPs since the previous classification.

62 Short telomeres are thus a signature in IIPs and likely play a role in their age-related onset.

63 95% CI = 0.25, 0.75; P = 0.0031) and non-IPF IIP (HR, 0.3; 95% CI = 0.15, 0.58; P = 0.005) had a lowe

64 s lower in patients with CTD-ILD and non-IPF IIP, compared with patients with IPF.

65 The unleached and leached IIP particles were characterised by X-ray diffraction, F

66 as studied during rebinding with the leached IIP particles as a function of pH, the weight of the pol

67 Cd(II) loaded IIP was further utilized to remove anionic dyes with >95

68 The mean IIP estimate was 5.9 days, with 95% expected between day

69 ultures of IIP fibroblasts compared with non-IIP fibroblasts, and CCL5, a CCR5 agonist, significantly

70 r levels of CCL7 were present in cultures of IIP fibroblasts compared with non-IIP fibroblasts, and C

71 systematic review is: What is the effect of IIP on crestal bone level (CBL) changes after at least 1

72 ystematic review is to examine the effect of IIP on MFR and PH after at least 12 months of functional

73 in CBL changes of 0.175 0.180 mm in favor of IIP without GBR when compared with implant with GBR.

74 BL changes of 0.179 +/- 0.174 mm in favor of IIP without GBR when compared with implant with GBR.

75 ured from patients with the severest form of IIP, namely usual interstitial pneumonia, exhibited the

76 lidating the successful functionalization of IIP with Au to produce IIP_Au NPs.

77 erapeutic effect in an experimental model of IIP, namely the bleomycin-induced model of pulmonary fib

78 de clues to the etiology and pathogenesis of IIP.

79 IL13-PE-mediated targeting of IIP fibroblasts was dependent on their expression of IL-

80 is particularly strong above a threshold of IIP = 1.6 (r = -0.6, p = 2e-4).

81 uided bone regeneration (GBR) at the time of IIP on crestal bone level (CBL) changes after at least 1

82 -17SCID/bg mice that received either type of IIP fibroblasts.

83 Both the genetics and the histologic type of IIP play a role in the etiology and pathogenesis of inte

84 to update the 2002 ATS/ERS classification of IIPs.

85 lmonary fibrosis (IPF) is the most common of IIPs and shares with IIPs an increased incidence with ag

86 Acute exacerbation of IIPs is now well defined.

87 the data to conduct three meta-analysis of "IIP using GBR versus IIP without GBR", "IIP using bone g

88 pulmonary fibroblast lines grown from other IIP SLBs and normal SLBs.

89 nts with UIP relative to patients with other IIP and patients without IIP, and that this CC chemokine

90 d with idiopathic interstitial pneumonia (PH-IIP).

91 In patients with PH-IIP, riociguat was associated with increased serious adv

92 and safety of riociguat in patients with PH-IIP.

93 iguat should not be used in patients with PH-IIP.

94 and safety of riociguat in patients with PH-IIP.

95 Immediate implant placement (IIP) into fresh extraction socket is a favorable treatme

96 Immediate implant placement (IIP) is a successful treatment and has the advantages of

97 Immediate implant placement (IIP) is predictable but can lead to esthetic challenges,

98 a high risk for immediate implant placement (IIP).

99 Idiopathic interstitial pneumonia (IIP) and its familial variants are progressive and large

100 h non-IPF idiopathic interstitial pneumonia (IIP), 46.5% of participants with chronic hypersensitivit

101 s such as idiopathic interstitial pneumonia (IIP), but it is not presently clear how this proliferati

102 forms of idiopathic interstitial pneumonia (IIP), such as usual interstitial pneumonia, can be imper

103 ents with idiopathic interstitial pneumonia (IIP).

104 ng events in idiopathic pulmonary pneumonia (IIP).

105 ubgroups (idiopathic interstitial pneumonia [IIP], idiopathic pulmonary fibrosis [IPF]) were stratifi

106 Idiopathic interstitial pneumonias (IIPs) are a collection of pulmonary fibrotic diseases of

107 The idiopathic interstitial pneumonias (IIPs) are a seemingly disconnected collection of disease

108 ation of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, and provided stan

109 Idiopathic interstitial pneumonias (IIPs) have a progressive and often fatal course, and the

110 fibrotic idiopathic interstitial pneumonias (IIPs; n = 1,616) and controls (n = 4,683), with follow-u

111 In this work a novel ion imprinted polymer (IIP) based on N-(pyridin-2-ylmethyl)ethenamine (V-Pic) w

112 method using antimony ion imprinted polymer (IIP) sorbent combined with electrothermal atomic absorpt

113 A new Zinc (II) ion-imprinted polymer (IIPs) nanoparticles was synthesised for the separation a

114 es of imidazolium-containing ionic polymers (IIP)s through orthogonal functionalization with gold nan

115 Instantaneous inhibitory potential (IIP), the log inhibition of single-round infectivity at

116 Instantaneous inhibitory potential (IIP), the log reduction in single-round infectivity at c

117 Instantaneous inhibitory potential (IIP), which integrates VRC01 serum concentration and VRC

118 ecent initiation/inactivation/proliferation (IIP) model characterized quantitatively the observed occ

119 with cis-encoded innate inhibiting proteins (IIPs) and determined the effect on protein expression an

120 The standard Internet Imaging Protocol (IIP) has been extended to enable arbitrary 2D sectioning

121 RISE-IIP was a double-blind, randomised, placebo-controlled s

122 inding covalently to the switch-II pocket (S-IIP) that is present only in the inactive guanosine diph

123 PDE5i treatment in severe IIP-PH and IPF-PH was associated with improved survival,

124 a magnetic ion-imprinted polymer (Fe3O4@SiO2@IIP) as a novel and selective nanosorbent for selective

125 from the lungs of 16 patients with sporadic IIP, 10 with familial IIP, and 9 normal control subjects

126 ssion profiles between familial and sporadic IIPs may provide clues to the etiology and pathogenesis

127 ferences exist between familial and sporadic IIPs, we identified only minor gene expression changes b

128 l differences exist in familial and sporadic IIPs.

129 meres contribute to disease risk in sporadic IIPs, we recruited patients who have no family history a

130 hanges with regard to one-stage or two-stage IIP protocol (-0.017 [95% CI, -0.249 to 0.216; P = 0.85]

131 The stochastic IIP analysis, unlike the deterministic one, indicates: (

132 ionalization had less MFR and better PH than IIP in thin biotype or with delayed restoration.

133 experiments provide a proof of concept that IIPs can be directly encoded into saRNA vectors and effe

134 Five-year survival in the IIP group was 51.9% (95% confidence interval [95% CI] 30

135 The maximum sorption capacity of the IIP for Sb(III) ions was found to be 6.7 mg g(-1).

136 orption and desorption of Pb(II) ions on the IIP particles were quite fast and achieved fully over 5

137 transcription (STAT) inhibitor, but not the IIPs, enhances protein expression of saRNA in vivo.

138 Categorization of the IIPs continues to be problematic despite recent attempts

139 itiating injury or injuries are unknown, the IIPs share a restricted number of final common abnormal

140 Intensive therapy (IIP or MDI) for 1 year.

141 role in the progression of fibrosis in this IIP patient group.

142 r, we here give a stochastic version of this IIP model.

143 es of reviews and clinical trials related to IIP was also performed.

144 al statistics of patients with PDE5i-treated IIP-PH or IPF-PH were validated in the independent COMPE

145 Type IIP restriction endonuclease AgeI recognizes a palindrom

146 R.SwaI, a Type IIP restriction endonuclease, recognizes a palindromic e

147 TaqI is a 263-amino acid (aa) Type IIP restriction enzyme that recognizes and cleaves withi

148 eavage mechanism of AgeI is novel among Type IIP restriction endonucleases.

149 rastically different from the canonical Type IIP mechanisms, and has allowed researchers to engineer

150 It is also the first type IIP methyltransferase whose catalytic activity is strong

151 double strand (ds) cleavage activity of Type IIP REases, which recognize 4-8 bp palindromic sequences

152 II, HinfI and TaqI), exclusively of the Type IIP class that recognize palindromic or interrupted-pali

153 out GBR", "IIP using bone graft alone versus IIP using bone graft with membrane" and "IIP using GBR v

154 three meta-analysis of "IIP using GBR versus IIP without GBR", "IIP using bone graft alone versus IIP

155 one graft versus without bone graft and with IIP with GBR compared with conventional implant placemen

156 ntrary to expectation, CTD-ILD compared with IIP appears to be associated with a worse prognosis when

157 ane showed better results when compared with IIP with bone graft alone [CBL changes of 0.532 +/- 0.57

158 ane showed better results when compared with IIP with bone graft alone [CBL changes of 0.532 0.572 mm

159 ported better CBL preservation compared with IIP with bone graft alone.

160 A substantial percentage of patients with IIP are difficult to classify, often due to mixed patter

161 gic variability is frequent in patients with IIP, patients with a histologic pattern of UIP in any lo

162 ecimens from multiple lobes in patients with IIP.

163 achieving predictable esthetic results with IIP presents a challenge because of naturally occurring

164 Intensive insulin therapy with IIP and MDI is effective in controlling non-insulin-depe

165 ) is the most common of IIPs and shares with IIPs an increased incidence with age and unexplained sca

166 patients with other IIP and patients without IIP, and that this CC chemokine may have a major role in

167 itial lung disease, but not patients without IIP, exhibited CCL7 gene expression.

168 tial lung disease, and from patients without IIP.